North America Breast Implants Market Report and Forecast 2024-2032

North America Breast Implants Market Outlook

The North America breast implants market size was valued at USD 0.8 billion in 2023, driven by the growing demand for breast implants in reconstructive surgery for breast cancer survivors along with the rising innovation in breast implant technology in the region. The market is expected to grow at a CAGR of 5.13% during the forecast period of 2024-2032, with the value likely to reach USD 1.2 billion by 2032.

Key Takeaways

• According to the National Breast Cancer Foundation, Inc., around 1 in 8 women are estimated to be diagnosed with breast cancer in their lifetime in the United States. Further, it is predicted that 310,720 women will be diagnosed with invasive breast cancer in 2024.

• In October 2023, Establishment Labs Inc., announced that the FDA granted 510(k) clearance for the Motiva Flora® SmoothSilk® Tissue Expander, the first-ever magnet-free, and MR conditional breast tissue expander (which permits women to undergo MRI). Such approvals are poised to impact the North America breast implants market share positively in coming years.

• In June 2023, a growth capital investment was made in Olympus Cosmetic Group (a provider of cosmetic surgery in the United States), aimed at supporting the development of a physician-owned platform and help to provide premium outcomes to its patients.

The surge in the demand for breast augmentation procedures, attributed to aesthetic reasons along with the rising prevalence of breast cancer in the region is likely to boost the North America breast implants market growth in the forecast period. According to the National Breast Cancer Foundation, Inc., around 1 in 8 women are estimated to be diagnosed with breast cancer in their lifetime in the United States. In addition, it is predicted that 310,720 women will be diagnosed with invasive breast cancer in 2024. Thus, the rising cases of breast cancer coupled with the advancements in reconstructive surgery for breast cancer survivors are expected to fuel the market demand in the forecast period.

The improvement in regulatory policies by health authorities such as the United States Food and Drug Administration (FDA) is likely to propel market growth. The availability of innovative products in healthcare facilities is anticipated to positively influence North America breast implants market demand. In October 2023, Establishment Labs Inc., a global medical technology company specializing in Femtech solutions for breast health, breast aesthetics, and breast reconstruction, announced that the FDA granted 510(k) clearance for the Motiva Flora® SmoothSilk® Tissue Expander. Titled as the first-ever magnet-free, and MR conditional breast tissue expander (which permits women to undergo magnetic resonance imaging (MRI)), its application has been approved in the United States market. Compared to other implant surfaces, SmoothSilk® has shown to exhibit minimum foreign body response and inflammation.

One of the significant North America breast implants market trends is the increased investment in the aesthetic surgery sector in order to meet the growing demand for breast augmentation and reconstruction procedures. In June 2023, a growth capital investment was made in Olympus Cosmetic Group (a provider of cosmetic surgery including breast augmentation and cosmetic dermatology procedures in the United States) by VSS Capital Partners, a New York-based private equity firm known for its investment in healthcare. The investment will support the development of this physician-owned platform and help to provide premium outcomes to its patients. Further, these investments also ensure the availability of skilled professionals and high-quality services, which is expected to bolster market growth in the region.

Other factors that impact the market landscape include the rise in technological innovation in breast implant technology, increasing economic growth, and growing disposable incomes in North America which allow more individuals to afford the cosmetic procedure.

North America Breast Implants Market Segmentation

North America breast implants market analysis offers a detailed breakup of the market based on the following segments:

North America Breast Implants Market: Competitor Landscape

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Establishment Labs SA

• GC Aesthetics

• Groupe Sebbin SAS

• Laboratories Arion

• Silimed

• Johnson & Johnson (Mentor Worldwide LLC)

• HansBioMed

• Cereplas

• Sientra Inc.

• AbbVie Inc. (Allergan PLC)

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

North America Breast Implants Market Report Snapshots

North America Breast Implants Market Size

North America Breast Implants Companies